Abstract: A computer-implemented method includes maintaining one or more databases that collectively store organizational data associated with an organization and an object graph data structure having a plurality of data objects associated with the organizational data. The method further includes generating a formula field which includes one or more dependent fields, wherein the formula field is defined and evaluated using a query expression that makes reference to the object graph data structure. The method further includes, in response to a value of at least one of the one or more dependent fields changing to an updated value, automatically updating a value of the formula field based on the updated value of the at least one of the one or more dependent fields, and enabling inclusion of the formula field in one or more of a report, a policy, a workflow, a trigger, or a rule.

Abstract: A condenser fan includes a lock hub and multiple blades that are fastened to the hub. Each of the blades includes six planes, each of which having variable parameters including pitch angle, sickle, chord length, and blade curve. For each embodiment of the evaporator fan, the blades are identically configured.

Abstract: Provided is a pharmaceutical formulation including (1S)-1-phenyl-2-pyridin-2-ylethanamine, a pharmaceutically acceptable salt thereof, a solvate thereof, or a prodrug thereof; and a pharmaceutically acceptable topical carrier. Also provided is a method for treating neuropathic pain by administering to a patient in need of such treatment a therapeutically effective amount of the pharmaceutical formulation.

Abstract: A computer-implemented method includes maintaining one or more databases that collectively store organizational data associated with an organization and an object graph data structure having a plurality of data objects associated with the organizational data. The method further includes generating a formula field which includes one or more dependent fields, wherein the formula field is defined and evaluated using a query expression that makes reference to the object graph data structure. The method further includes, in response to a value of at least one of the one or more dependent fields changing to an updated value, automatically updating a value of the formula field based on the updated value of the at least one of the one or more dependent fields, and enabling inclusion of the formula field in one or more of a report, a policy, a workflow, a trigger, or a rule.

Abstract: A centrifugal blower includes a blower base, multiple blades fastened to the blower base, a hub integrated to a central portion of the blower base, and a top shroud to provide surrounding coverage to the multiple blades. The centrifugal blower is housed within an evaporator. The centrifugal blower may operate at operating speeds that are lower than those of typical or currently known implementations while generating an airflow that meets or even exceeds those of the typical or currently known implementations.

Abstract: A condenser fan includes a lock hub and multiple blades that are fastened to the hub. Each of the blades includes six planes, each of which having variable parameters including pitch angle, sickle, chord length, and blade curve. For each embodiment of the evaporator fan, the blades are identically configured.

Abstract: Some examples described herein relate to cluster formation. In an example, on a cluster management system, a cluster formation image may be provided for forming a cluster of nodes. The cluster formation image may comprise a compressed version of an operating system, and a plan script comprising custom attributes for customizing the operating system and instructions for forming the cluster. In response to a selection of the cluster formation image, the cluster formation image may be provided from the cluster management system to each of the nodes. The operating system may be installed on each of the nodes, and the operating system on each of the nodes may be customized based on the custom attributes in the plan script. The nodes may be formed into a cluster based on the instructions in the plan script.

Abstract: A polymeric composition for making aqueous polymeric dispersions, comprises hydrophilic macromonomer (I), hydrophobic polymer (II) and bridging monomer (III), wherein the hydrophilic macromonomer (I) and hydrophobic polymer (II) are grafted together in the presence of bridging monomer (III) and the hydrophilic macromonomer (I) has a structure according to formula (1): R—C(X)?CH2, wherein R is a polymeric group and X is a radical stabilizing group. The aqueous polymeric composition is used for making a coating composition, a printing ink, an adhesive, a sealant or caulking material.

Abstract: Provided herein are plants having altered expression of a GAUT polypeptide. Such plants have phenotypes that may include decreased recalcitrance, increased growth, decreased lignin content, or a combination thereof. Also provided herein are methods of making and using such plants.

Abstract: A 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diasterisomer is described which is a better inhibitor of topoisomerase I than either the diastereoisomeric mixture 5(RS)-(2?-hydroxyethoxy)-20(S)-camptothecin, or the 5(R)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer. Pharmaceutical compositions of the 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer are also described as are methods of using the compound for the inhibition of topoisomerase I and for the treatment of cancer.

Abstract: A 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diasterisomer is described which is a better inhibitor of topoisomerase I than either the diastereoisomeric mixture 5(RS)-(2?-hydroxyethoxy)-20(S)-camptothecin, or the 5(R)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer. Pharmaceutical compositions of the 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer are also described as are methods of using the compound for the inhibition of topoisomerase I and for the treatment of cancer.

Abstract: A 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diasterisomer is described which is a better inhibitor of topoisomerase I than either the diastereoisomeric mixture 5(RS)-(2?-hydroxyethoxy)-20(S)-camptothecin, or the 5(R)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer. Pharmaceutical compositions of the 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer are also described as are methods of using the compound for the inhibition of topoisomerase I and for the treatment of cancer.

Abstract: A crystalline form of 5(S)-(2?-hydroxyethoxy)-20(S)-camptothecin diastereoisomer of 5(RS)-(2?-hydroxyethoxy)-20(S)-camptothecin is described that is characterized by having an X-ray powder diffraction pattern comprising one or more peak intensities expressed in degrees 2? that are selected from the group consisting of 7.2±0.1, 9.4±0.1, 11.02±0.1, 12.00±0.1, 14.54±0.1, 15.2±0.1, 18.92±0.1, 21.86±0.1, 22.74±0.1 and 26.42±0.1. Methods of making and using the compound are also described.

Abstract: The present invention relates to the selection and development of superior strain of Bacillus spp for improving plant growth and health by inhibiting pathogenic fungi.

Abstract: The present invention relates to the selection and development of superior strain of Bacillus spp for improving plant growth and health by inhibiting pathogenic fungi

Abstract: The present invention relates to a new strain of Streptomyces sp., called CIMAP A1 isolated from the soil of geranium (Pelargonium graveolens) planted in the experimental fields of CIMAP and having the accession No. ATCC PTA-4131 and capable of inhibiting the growth of phytopathogenic fungi.

Abstract: The present invention relates to a new strain of Streptomyces sp., called CIMAP A1 isolated from the soil of geranium (Pelargonium graleoleus) planted in the experimental fields of CIMAP and having the accession No. . . . and capable of inhibiting the growth of phytopathogenic fungi.

Abstract: A swirl or pitch changing chamber (16) is interposed at the convergence of a plurality of divergent pneumatic forwarding tubes (11, 12) and communicates with the tubes (11, 12). In the chamber (16), a transporter capsule (15) is caused to perform a complex motion, the motion being predominantly a pitch changing translation, by use of mechanical, electromagnetic, magnetic and/or pneumatic forces caused to act on the capsule (15), thereby accomplishing a desired change in the direction of longitudinal travel of the capsule (15). The chamber (16) is defined by an enlargement in the transverse dimension of the tubes (11, 12), the dimensions of the chamber (16) being sufficient to accommodate the complex motion.

Abstract: A hand held device for preparation of beverages of desired composition and strength has a source stuff (11) of the beverage packaged in a porous pouch (14) supported on a cage framework (12), emanating downwards from a pedestal (16), and the pouch (14) is encased within the device in cavity of a concave cap (13). A plurality of capsules (22,32), each containing an adjunct (21,31) of the beverage respectively, are mounted above the pedestal (16) to form a portable pencil of capsules. The framework (12) and the pouch (14) containing the stuff (11) cooperate as a commingling infuser stirrer, when shuffled in the liquid medium of the beverage, thereby enhancing combination of the stuff (11) and the medium. Fork (44) and knife (43) projections protrude on exterior of the cap (13). A fluid is injectible through the stuff (11) and the prepared beverage.

Abstract: An improved method of evaluating molecular structures using relativistic integral equations. The method transforms Cartesian non-relativistic integrals into relativistic integrals using a two-step process. A first step transforms two indecises of the non-relativistic integral equations into a plurality of intermediate equations. A second step transforms the plurality of intermediate set of integrals into relativistic integral. The relativistic integrals are then used to evaluate the relativistic behavior of the molecular structure.